Molecular changes in the postmortem parkinsonian brain.

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Parkinson disease (PD) is the second leading neurodegenerative disorder.
• Its etiology is complex, involving multiple biochemical and genetic factors.
• Post-mortem brain analysis has been vital in identifying pathogenic pathways.

Purpose of the Study:

• To review biochemical defects in post-mortem Parkinson disease brains.
• To explore the relevance of these defects to neurodegeneration.
• To highlight interactions between pathways and genetic risk factors for PD.

Main Methods:

• Comprehensive review of post-mortem Parkinson disease brain biochemistry.
• Analysis of molecular alterations including neurotransmitters, Lewy bodies, metals, inflammation, and mitochondrial function.
• Classification of molecular changes related to PD pathogenesis.

Main Results:

• Identified spectrum of biochemical defects in PD brains.
• Highlighted the significance of mitochondrial and lysosomal pathways.
• Documented interactions between biochemical pathways and PD-associated genes.

Conclusions:

• Post-mortem brain biochemistry is crucial for understanding PD etiology.
• Interactions between pathways and genes offer therapeutic targets.
• Further research into these pathways may lead to disease-modifying therapies for Parkinson disease.